Landsberg Bennett & Dubbaneh’s AbbVie ABBV Stock Holding History

Landsberg Bennett & Dubbaneh’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$826K	Buy	7,575 +67	+0.9%	+$7.66K	0.11%	132
2021 Q2	$843K	Buy	7,508 +30	+0.4%	+$3.38K	0.11%	136
2021 Q1	$812K	Buy	7,478 +431	+6%	+$46.1K	0.12%	131
2020 Q4	$755K	Buy	7,047 +43	+0.6%	+$4.13K	0.12%	122
2020 Q3	$609K	Buy	7,004 +182	+3%	+$17.1K	0.11%	130
2020 Q2	$658K	Buy	6,822 +564	+9%	+$49.7K	0.14%	130
2020 Q1	$470K	Buy	6,258 +213	+4%	+$18.1K	0.13%	114
2019 Q4	$535K	Buy	6,045 +5	+0.1%	+$415	0.13%	141
2019 Q3	$452K	Sell	6,040 -743	-11%	-$50.9K	0.12%	147
2019 Q2	$498K	Sell	6,783 -496	-7%	-$39K	0.13%	150
2019 Q1	$605K	Sell	7,279 -17,287	-70%	-$1.41M	0.14%	142
2018 Q4	$2.27M	Buy	+24,566	New	+$2.16M	0.87%	31

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Landsberg Bennett & Dubbaneh's ABBV Position: Q3 2021 in Review

Landsberg Bennett & Dubbaneh increased its AbbVie (ABBV) stake by 0.89% in Q3 2021, buying an estimated $7.66K and bringing the position to 7,575 shares worth $826K. The position accounts for 0.11% of the portfolio, ranked #132.

Landsberg Bennett & Dubbaneh first reported a position in ABBV in Q4 2018 and has held it in 12 quarters since. The position peaked at $2.27M in Q4 2018. 2,655 funds tracked by Wall St. Rank hold ABBV as of Q3 2021.

Landsberg Bennett & Dubbaneh held 7,575 shares of AbbVie worth $826K as of Q3 2021.
Landsberg Bennett & Dubbaneh bought 67 AbbVie shares in Q3 2021, an estimated $7.66K.
AbbVie made up 0.11% of Landsberg Bennett & Dubbaneh's portfolio in Q3 2021, its #132 holding.
Landsberg Bennett & Dubbaneh first reported a position in AbbVie in Q4 2018 and has held it in 12 quarters since.
Landsberg Bennett & Dubbaneh's AbbVie position peaked at $2.27M in Q4 2018.
2,655 funds tracked by Wall St. Rank held AbbVie as of Q3 2021.

Based on Landsberg Bennett & Dubbaneh's 13F filing for Q3 2021, filed 29 Oct 2021.